Antibiotic resistance in Helicobacter pylori: Implications for therapy

Gastroenterology

Volumn 115, Issue 5, 1998, Pages 1272-1277

  Graham, D Y ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BIOFILM; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; REVIEW; STOMACH PH;

EID: 0031732311     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70100-3     Document Type: Article

References (36)

1. J Versalovic D Shortridge K Kibler MV Griffy J Beyer RK Flamm SK Tanaka DY Graham MF Go Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori Antimicrob Agents Chemother 40 1996 477 480
2. J Versalovic MS Osato K Spakovsky MP Dore R Reddy GG Stone D Shortridge RK Flamm SK Tanaka DY Graham Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance J Antimicrob Chemother 40 1997 283 286
3. MP Dore DY Graham A Sepulveda PBP-D, a novel penicillin-binding protein is involved in amoxicillin resistance in Helicobacter pylori (abstr) Gastroenterology 114 1998 A109
4. L Engstrand DY Graham A Schelnius RM Genta FAK El-Zaatari Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular? Am J Clin Pathol 108 1997 504 509
5. DY Graham DG Evans Prevention of diarrhea caused by enterotoxigenic Escherichia coli : lessons learned with volunteers Rev Infect Dis 12 suppl 1 1990 S68 S72
6. DY Graham GM Börsch The who's and when's of therapy for Helicobacter pylori Am J Gastroenterol 85 1990 1552 1555
7. R Grant MI Grossman AC Ivy Histological changes in the gastric mucosa during digestion and their relationship to mucosal growth Gastroenterology 25 1953 218 231
8. G Willems Trophicity of gastric epithelium and its regulation M Mignon J-P Galmiche Safe and effective control of acid secretion 1988 John Libbey Eurotext Paris 39 50
9. GM Börsch DY Graham Helicobacter pylori . Pharmacology of peptic ulcer disease MJ Collen SB Benjamin Handbook of experimental pharmacology Volume 99 1991 Springer-Verlag Berlin 107 148
10. RH Hunt Hp and pH: implications for the eradication of Helicobacter pylori Scand J Gastroenterol Suppl 196 1993 12 16
11. ML Grayson GM Eliopoulos MJ Ferraro RC Moellering Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents Eur J Clin Microbiol Infect Dis 8 1989 888 889
12. CS Goodwin CAM McNulty Bacteriological and pharmaceutical basis for the treatment of Helicobacter pylori infection 2nd ed B Rathbone V Vealtley Helicobacter pylori and gastrointestinal disease 1992 Blackwell Scientific London 224 231
13. DY Graham JL Smith AA Bouvet What happens to tablets and capsules in the stomach: endoscopic comparison of disintegration and dispersion characteristics of two microencapsulated potassium formulations J Pharm Sci 79 1990 420 424
14. KS Graham H Malaty HM el-Zimaity RM Genta RA Cole MT Al-Assi MM Yousfi GA Neil DY Graham Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection Am J Gastroenterol 90 1995 1415 1418
15. BJ Marshall Treatment strategies for Helicobacter pylori infection Gastroenterol Clin North Am 22 1993 183 198
16. MT Al-Assi RM Genta DY Graham Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection Aliment Pharmacol Ther 8 1994 259 262
17. DY Graham R Genta DG Evans R Reddy JE Clarridge CA Olson AL Edmonds N Siepman Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole Am J Gastroenterol 91 1996 2120 2124
18. JM Gotz RA Veenendaal M Veselic S Bernards CB Lamers Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori Scand J Gastroenterol Suppl 212 1995 34 37
19. MM Yousfi HM el-Zimaity RA Cole RM Genta DY Graham Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy) Aliment Pharmacol Ther 10 1996 119 122
20. S Miederer Triple ranitidine therapy in Helicobacter pylori infection: recommendation for effective, safe and cost effective combination for Helicobacter pylori eradication Fortschr Med 114 1996 460 462
21. K Kihira K Satoh K Saifuku Y Taniguchi T Takimoto H Yamamoto K Ido Y Yoshida K Kimura Comparison of ranitidine and lansoprazole in short-term low-dose triple therapy for Helicobacter pylori infection Aliment Pharmacol Ther 11 1997 511 514
22. M Lazzaroni S Bargiggia GB Porro Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori -associated duodenal ulcer Am J Gastroenterol 92 1997 649 652
23. E Hentschel G Brandstatter B Dragosics AM Hirschl H Nemec K Schutze M Taufer H Wurzer Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer N Engl J Med 328 1993 308 312
24. RJ Adamek W Opferkuch M Wegener Modified short-term triple therapy—ranitidine, clarithromycin, and metronidazole—for cure of Helicobacter pylori infection (letter) Am J Gastroenterol 90 1995 168 169
25. TC Tham JS Collins C Molloy JM Sloan KB Bamford RG Watson Randomised controlled trial of ranitidine versus omeprazole in combination with antibiotics for eradication of Helicobacter pylori Ulster Med J 65 1996 131 136
26. WA de Boer How to achieve a near 100% cure rate for H. pylori infection in peptic ulcer patients: a personal viewpoint J Clin Gastroenterol 22 1996 313 316
27. RWM van der Hulst JJ Keller EA Rauws GNJ Tytgat Treatment of Helicobacter pylori infection in humans: a review of the world literature Helicobacter 1 1996 6 19
28. F Megraud P Trimoulet H Lamouliatte L Boyanova Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells Antimicrob Agents Chemother 35 1991 869 872
29. DG Evans DJ Evans Adhesion properties of Helicobacter pylori Methods Enzymol 253 1995 336 360
30. T Boren S Normark P Falk Helicobacter pylori : molecular basis for host recognition and bacterial adherence Trends Microbiol 2 1994 221 228
31. PM Simon PL Goode A Mobasseri D Zopf Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides Infect Immun 65 1997 750 757
32. RM Genta RM Huberman DY Graham The gastric cardia in Helicobacter pylori infection Hum Pathol 25 1994 915 919
33. PD Midolo J Turnidge JR Lambert JM Bell Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori Diagn Microbiol Infect Dis 21 1995 135 140
34. DY Graham GM Lew DG Evans DJ Evans Jr Klein PD. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing: a randomized controlled trial Ann Intern Med 115 1991 266 269
35. KD Bardhan E Bayerdörffer J Delchier M Hellblom F Megraud A Stubberod SJ Veldhuyzen van Zanten T Lind C Burman P Gromark H. pylori (Hp) eradication with omeprazole (O), metronidazole (M) and amoxicillin (A): the impact of drug dosing & resistance on efficacy—the Homer story (abstr) Gastroenterology 114 1998 A65
36. DY Graham WA de Boer GN Tytgat Choosing the best anti- Helicobacter pylori therapy: effect of antimicrobial resistance Am J Gastroenterol 91 1996 1072 1076